Menu
GeneBe

C5AR1

complement C5a receptor 1, the group of Complement component GPCRs|Complement system regulators and receptors|CD molecules

Basic information

Region (hg38): 19:47290022-47322066

Previous symbols: [ "C5R1" ]

Links

ENSG00000197405NCBI:728OMIM:113995HGNC:1338Uniprot:P21730AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the C5AR1 gene.

  • Inborn genetic diseases (11 variants)
  • not provided (6 variants)
  • C5AR1-related condition (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the C5AR1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
1
clinvar
3
missense
13
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
3
clinvar
3
Total 0 0 13 2 4

Variants in C5AR1

This is a list of pathogenic ClinVar variants found in the C5AR1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-47319781-G-G Benign (Dec 31, 2019)769025
19-47319863-C-A not specified Uncertain significance (Dec 22, 2023)3136040
19-47319877-C-T C5AR1-related disorder Uncertain significance (May 08, 2023)2631913
19-47319907-T-C not specified Uncertain significance (Sep 28, 2022)2347104
19-47319932-T-C not specified Uncertain significance (Aug 17, 2022)2346890
19-47320012-G-A not specified Uncertain significance (Apr 22, 2022)2215426
19-47320066-G-A not specified Likely benign (Aug 10, 2021)3136034
19-47320072-C-T not specified Uncertain significance (Dec 26, 2023)3136035
19-47320093-G-A C5AR1-related disorder • not specified Uncertain significance (May 08, 2023)2204214
19-47320227-T-T Benign (Dec 31, 2019)770810
19-47320267-G-T not specified Uncertain significance (Nov 09, 2022)2369843
19-47320268-C-A not specified Uncertain significance (Jan 04, 2022)2388591
19-47320286-C-A C5AR1-related disorder Uncertain significance (Mar 27, 2023)2633744
19-47320309-C-T C5AR1-related disorder Uncertain significance (Dec 29, 2023)3047971
19-47320314-G-A Likely benign (Dec 31, 2019)744644
19-47320330-A-C not specified Uncertain significance (Jan 10, 2022)2271407
19-47320333-G-T not specified Uncertain significance (Dec 07, 2023)3136036
19-47320392-C-G Benign (Jun 12, 2018)770291
19-47320434-G-A C5AR1-related disorder Likely benign (Sep 19, 2023)718843
19-47320459-C-T not specified Uncertain significance (Feb 28, 2024)3136037
19-47320556-T-G not specified Uncertain significance (Apr 25, 2022)3136038
19-47320589-C-T not specified Uncertain significance (Dec 21, 2023)3136039
19-47320590-G-A C5AR1-related disorder Likely benign (Sep 04, 2023)3051110
19-47320614-G-G Benign (Dec 31, 2019)769026
19-47320623-C-G not specified Uncertain significance (Jun 06, 2022)2213719

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
C5AR1protein_codingprotein_codingENST00000355085 232044
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.4020.48000000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1582112180.9700.00001502235
Missense in Polyphen8186.8970.93213921
Synonymous-0.6701091001.080.00000693792
Loss of Function0.96401.080.004.60e-812

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a (PubMed:1847994, PubMed:8182049, PubMed:7622471, PubMed:9553099, PubMed:10636859, PubMed:15153520, PubMed:29300009). The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N- terminus, and a second site in the transmembrane region which activates downstream signaling events (PubMed:8182049, PubMed:7622471, PubMed:9553099). Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production (PubMed:10636859, PubMed:15153520). {ECO:0000269|PubMed:10636859, ECO:0000269|PubMed:15153520, ECO:0000269|PubMed:1847994, ECO:0000269|PubMed:29300009, ECO:0000269|PubMed:7622471, ECO:0000269|PubMed:8182049, ECO:0000269|PubMed:9553099}.;
Pathway
Complement and coagulation cascades - Homo sapiens (human);Staphylococcus aureus infection - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;Human Complement System;Dengue-2 Interactions with Complement and Coagulation Cascades;Oxidative Damage;Complement and Coagulation Cascades;Signaling by GPCR;Neutrophil degranulation;Signal Transduction;Innate Immune System;Immune System;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Regulation of Complement cascade;G alpha (i) signalling events;Complement cascade;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.466

Intolerance Scores

loftool
0.650
rvis_EVS
-0.6
rvis_percentile_EVS
18.14

Haploinsufficiency Scores

pHI
0.136
hipred
N
hipred_score
0.213
ghis
0.542

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.715

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
C5ar1
Phenotype
homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; skeleton phenotype; immune system phenotype;

Gene ontology

Biological process
activation of MAPK activity;complement receptor mediated signaling pathway;apoptotic process;chemotaxis;inflammatory response;immune response;cellular defense response;signal transduction;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;activation of phospholipase C activity;positive regulation of cytosolic calcium ion concentration;sensory perception of chemical stimulus;positive regulation of vascular endothelial growth factor production;positive regulation of macrophage chemotaxis;cell proliferation in hindbrain;regulation of complement activation;neutrophil chemotaxis;animal organ regeneration;response to peptidoglycan;response to lipopolysaccharide;complement component C5a signaling pathway;mRNA transcription by RNA polymerase II;neutrophil degranulation;negative regulation of neuron apoptotic process;positive regulation of angiogenesis;positive regulation of epithelial cell proliferation;defense response to Gram-positive bacterium;positive regulation of ERK1 and ERK2 cascade;positive regulation of neutrophil chemotaxis
Cellular component
plasma membrane;integral component of plasma membrane;cell surface;basolateral plasma membrane;secretory granule membrane;apical part of cell
Molecular function
complement component C5a binding;complement component C5a receptor activity;G protein-coupled receptor activity